Experimental Drug Yields Dramatic Weight Loss

Chronological Source Flow
Back

AI Fusion Summary

Eli Lilly’s experimental injectable drug Retatrutide, developed at its Indianapolis headquarters, targets three hormones linked to weight loss and has shown dramatic weight loss in early studies, positioning it as a next‑generation obesity treatment.
Community Comments
Loading updates...
0